FilingIndex
← The Wire
BVSNasdaq

Bioventus Inc.

Surgical & Medical Instruments & Apparatus · DE · CIK 1665988

Bioventus Inc. provides innovative medical devices for pain relief and musculoskeletal challenges

$577M
Market cap
$9.78
Last close
0.0%
1D
+11.3%
5D
583K
Volume
Price · last 39 sessions-3.8%
May 4L $7.93 · H $10.94Jun 29
125
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 4, 20268-KReg FD DisclosureMay 21, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 202610-K10-KMar 5, 20268-KResults of OperationsMar 5, 20268-KExecutive ChangeNov 17, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KMaterial Agreement · New Debt / ObligationAug 4, 20258-KCompany UpdateJul 31, 20258-KShareholder VoteJun 4, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 22, 2025DEF 14ADEF 14AApr 22, 202510-K10-KMar 11, 20258-KResults of OperationsMar 11, 20258-KAcquisition / Disposition · Company UpdateJan 3, 202510-Q10-QNov 5, 20248-KResults of OperationsNov 5, 20248-KMaterial Agreement · Company UpdateOct 4, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 20248-KCompany UpdateJul 19, 20248-KMaterial AgreementJun 21, 20248-KSecurity-Holder Rights · Bylaw AmendmentJun 17, 2024DEFA14ADEFA14AJun 3, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 202410-K10-KMar 12, 20248-KResults of OperationsMar 12, 20248-KMaterial AgreementJan 19, 20248-KExecutive ChangeJan 12, 20248-KExecutive Change · Reg FD DisclosureDec 21, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KExecutive Change · Shareholder VoteJun 9, 20238-KAcquisition / Disposition · Company UpdateMay 26, 202310-Q10-QMay 16, 20238-KResults of OperationsMay 16, 20238-KMaterial Agreement · Reg FD DisclosureMay 16, 20238-KResults of OperationsMay 11, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-K/AExecutive ChangeApr 11, 20238-KExecutive ChangeApr 5, 202310-K10-KMar 31, 20238-KResults of OperationsMar 31, 20238-KAcquisition / DispositionMar 3, 20238-KMaterial Agreement · Reg FD DisclosureFeb 28, 2023SC 13GSC 13GFeb 14, 20238-KExecutive ChangeJan 9, 20238-KExit / Disposal CostsDec 7, 20228-K/AResults of OperationsNov 21, 202210-Q10-QNov 21, 20228-KResults of OperationsNov 16, 20228-KResults of OperationsNov 8, 20228-K/ACompany UpdateSep 27, 20228-KExecutive ChangeSep 1, 202210-Q10-QAug 12, 20228-KResults of OperationsAug 11, 2022SC 13DSC 13DJul 21, 20228-KMaterial Agreement · Acquisition / DispositionJul 12, 20228-KExecutive ChangeJun 29, 20228-KMaterial AgreementJun 22, 20228-KShareholder VoteJun 21, 202210-Q10-QMay 11, 20228-KResults of OperationsMay 10, 2022DEFA14ADEFA14AApr 29, 2022DEF 14ADEF 14AApr 29, 20228-KResults of Operations · Reg FD DisclosureApr 26, 2022

Insider Activity

In the 90 days to Mar 11, 2026: 1 sold $105K.

DateInsiderActionSharesPriceValue
Mar 11, 2026Mcmurry-Heath MichelleDirectorSell12,000$8.79$105K
Dec 4, 2025Nohra Guy PDirectorSell10,000$7.57$76K
Nov 7, 2025Mcmurry-Heath MichelleDirectorSell17,701$7.42$131K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance